Verastem Oncology Information
Contact top employees from
Verastem Oncology
Summary
Verastem Oncology is a public company that has been in the industry for 15 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position of the CEO is occupied by Brian Stuglik. Its headquarters is located at Needham, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Verastem Oncology varies between 25M and 100M. Total funding of the company - $234.2M. To connect with Verastem Oncology employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
Oncology, pharmaceutical, biotechnology, cancer, clinical trials, cancer research
SIC Code
2834, 2836
DMA Code
Greater Boston
Founded
2010
Estimated Annual Revenue
$25M - 100M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1998 | Public Company | 100 - 250 | 57.8M | $405.9M | |
| 2018 | Privately Held | 1 - 25 | < 1M | $534M | |
| 2011 | Public Company | 250 - 500 | 2.4M | $128.1M | |
| 2000 | Public Company | 25 - 100 | 40.9M | $119.2M | |
| 2013 | Public Company | 1.0K - 5.0K | 106M | $1.5B | |
| 2009 | Privately Held | 25 - 100 | 5.6M | $197.7M | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 2016 | Privately Held | 25 - 100 | < 1M | $463M | |
| 2001 | Public Company | 1 - 25 | 4.6M | $141.4M | |
| 2018 | Privately Held | 25 - 100 | 2.5M | $113.8M | |
| 2007 | - | 100-200 | - | $- | |
| 1991 | - | 1000-5000 | - | $- | |
| 2011 | - | 100-200 | - | $- | |
| 2006 | - | 10-50 | - | $- | |
| 2012 | - | 100-200 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Length of Employment
Employee tenure at Verastem Oncology shows a diverse range of experience levels:
15% have been with the company for less than 1 year11% for 1–2 years7% for 3–4 years35% for 5–7 years13% for 8–10 years20% have over 11 years of service at Verastem OncologyEx-employees positions
In Company
In New Company
Contact top employees from
Verastem Oncology
Sheena Clift
Senior Clinical Trial Manager
John Hayslip
Chief Medical Officer
Debbie Jedrzejczyk
Oncology Account Manager
Michael Polkowitz
Strategic Account Director - GPO/Organized Customers
Christiane Carney
National Field Leader, Senior Director Medical Affairs (Solid Tumor)
C LeAnn Humphries
Clinical Trial Project Manager
Rabeya Molla
Medical Science Liaison
Yatin Patel
Associate Director, Product Development, Manufacturing and CMC
Kellen Meadows
Senior Director, Clinical Science
Michael Dowd
VP, Program and Collaboration Lead
Nathan Sanburn
Chief Business Officer
Diana Fitch
Quality Systems Manager
Jameson Ellett
Director, Medical Affairs Strategy and Operations
Daphne Wei
Oncology Sales Specialist
Ryan Jamieson
Translational Researcher
Gina Bailey
Director, Program Management
John McCartney
Vice President of Medical Writing
Ashley Switzer
Senior Clinical Trial Manager
Jennifer Sams
Oncology Account Manager
Richa Rathore
Senior Medical Science Liaison
Matthew Ros
Chief Operating Officer
Meagan Vogt
Senior Medical Science Liaison, Gynecologic, GI, and Thoracic Oncology
Andrea Solomon
Oncology Account Manager
Scott Barrett
SVP, Head of Clinical Development
Ashley Glynn
Senior Executive Assistat
Similar Companies
FAQ
Verastem Oncology operates in the Biotechnology industries. More details can be found on the official website: verastem.com.
The headquarters of Verastem Oncology are located in Needham, United States.
The current CEO of Verastem Oncology is Brian Stuglik
You can contact Verastem Oncology by phone at 1-781-292-4200.
Verastem Oncology currently employs 100-200 people.
Verastem Oncology's revenue is approximately 80.7M.
Well-known competitors of Verastem Oncology include Cytokinetics, Day One Biopharmaceuticals, TG Therapeutics, Inc. and Lite Strategy.
